So I think the promise here is a medication that gives us moderate weight loss, which is sufficient in the majority of our patients to improve their health, to meet our patients needs for weight loss, to meet our health goals in terms of preventing and treating obesity-related complications with a well-tolerated medication
The inactive ingredients present in it are dibasic sodium phosphate (2.84 mg), benzyl alcohol (18 mg), sodium hydroxide (2.86 mg), and sodium chloride (8.76 mg)
It is studied for its role in tissue healing and the integrity of the gut lining, making it a common starting point for women who feel they recover slowly from training or daily strain
But these benefits are mostly from animal studies, and no major regulator has approved BPC157 for routine human therapy
Neither BPC-157 nor TB-500 is FDA-approved, both are sold for laboratory research use only, and TB-500 (thymosin beta-4 and its fragments) is prohibited in sport by WADA